|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 366.50 USD | -3.26% |
|
+0.21% | +7.71% |
| 20/01 | GSK plc entered a definitive agreement to acquire RAPT Therapeutics, Inc. for $1.6 billion. | CI |
| 16/01 | William O'Neil Initiates Coverage on Evercore With Buy Rating | MT |
Company Valuation: Evercore Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 4,455 | 5,301 | 4,236 | 6,444 | 10,552 | 14,176 | 14,176 | - |
| Change | - | 18.99% | -20.08% | 52.11% | 63.76% | 34.34% | 0% | - |
| Enterprise Value (EV) 1 | 4,002 | 5,099 | 4,236 | 7,252 | 11,382 | 15,247 | 15,247 | 15,247 |
| Change | - | 27.41% | -16.91% | 71.18% | 56.95% | 33.95% | 0% | 0% |
| P/E ratio | 13.3x | 7.95x | 9.4x | 26.9x | 30.5x | 27.8x | 25.3x | 17x |
| PBR | 3.64x | 3.91x | - | 4.1x | 6.19x | 7.22x | 6.59x | 5.36x |
| PEG | - | 0x | -0.3x | -0.6x | 0.7x | 0.6x | 2.59x | 0.3x |
| Capitalization / Revenue | 1.91x | 1.6x | 1.52x | 2.63x | 3.51x | 3.85x | 3.13x | 2.75x |
| EV / Revenue | 1.72x | 1.54x | 1.52x | 2.96x | 3.79x | 4.14x | 3.37x | 2.96x |
| EV / EBITDA | 6.01x | 4.37x | 5.65x | 17.7x | 19.6x | 19.6x | 13.5x | 10.5x |
| EV / EBIT | 6.26x | 4.48x | 5.86x | 18.8x | 20.4x | 20.1x | 13.9x | 10.9x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 2.35 | 2.72 | 2.88 | 3.04 | 3.16 | 3.419 | 3.569 | 3.791 |
| Rate of return | 2.14% | 2% | 2.64% | 1.78% | 1.14% | 0.93% | 0.97% | 1.03% |
| EPS 2 | 8.22 | 17.08 | 11.61 | 6.37 | 9.08 | 13.18 | 14.47 | 21.61 |
| Distribution rate | 28.6% | 15.9% | 24.8% | 47.7% | 34.8% | 25.9% | 24.7% | 17.5% |
| Net sales 1 | 2,327 | 3,317 | 2,786 | 2,449 | 3,003 | 3,683 | 4,525 | 5,151 |
| EBITDA 1 | 665.5 | 1,166 | 750.4 | 409.8 | 581.7 | 779.4 | 1,130 | 1,446 |
| EBIT 1 | 639.3 | 1,138 | 722.7 | 385.4 | 557.3 | 757.8 | 1,095 | 1,397 |
| Net income 1 | 350.6 | 740.1 | 476.5 | 255.5 | 378.3 | 563.3 | 620.9 | 892 |
| Net Debt 1 | -453.1 | -202.1 | - | 808.1 | 830.1 | 1,071 | 1,071 | 1,071 |
| Reference price 2 | 109.64 | 135.85 | 109.08 | 171.05 | 277.19 | 366.50 | 366.50 | 366.50 |
| Nbr of stocks (in thousands) | 40,632 | 39,019 | 38,838 | 37,673 | 38,069 | 38,678 | 38,678 | - |
| Announcement Date | 03/02/21 | 02/02/22 | 01/02/23 | 31/01/24 | 05/02/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.81x | 4.14x | 19.56x | 0.93% | 1.42TCr | |
| 19.32x | 11.35x | - | 1.49% | 30TCr | |
| 18.35x | 7.38x | - | 2.12% | 29TCr | |
| 15.7x | - | - | 2.06% | 20TCr | |
| 21.64x | 7.65x | 13.13x | 1.07% | 18TCr | |
| 14.26x | 1.3x | - | 2.43% | 5.86TCr | |
| 14.55x | - | - | 1.3% | 3.31TCr | |
| 34.13x | 2.15x | 14.32x | 0.34% | 2.94TCr | |
| 12.65x | 6.5x | - | 2.34% | 2.82TCr | |
| 11.6x | 7.34x | - | 3.52% | 2.68TCr | |
| Average | 19.00x | 5.97x | 15.67x | 1.76% | 11.51TCr | |
| Weighted average by Cap. | 18.56x | 8.07x | 13.70x | 1.75% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- EVR Stock
- Valuation Evercore Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition